Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives
Investing in IPOs

Tim Eisenhauer, Managing Director of OnMarket BookBuilds recently published this article on LinkedIn which we thought might be of interest to the IR Department audience.
Tim writes: "Not all IPOs are created equal. If you’re going to put your hard earned cash into the public float of a company, what are the markers of a good investment? Below are seven suggested tests that you should subject any new issue to that will hopefully put you on the plus side of the ledger when the shares actually list on the ASX."

